Ahead of the FDA decision on MDMA-assisted therapy to treat PTSD this summer, van der Kolk shares his thoughts on the logistics of care.

Part 1 of our interview with van der Kolk: [ Ссылка ]

Part 2: [ Ссылка ]

-------

Stay tuned for HCPLive's day-long coverage of the FDA Psychopharmacologic Drugs Advisory Committee meeting on Tuesday, June 6 at HCPLive.com.

And join us for a livestream interview with Franklin King, MD, Psychiatrist and Instructor at Mass General Hospital and Harvard Medical School!

Set your reminder here: [ Ссылка ]

свернуть